×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Immunome Announces Completion of Purchase of Assets from Atreca
Business Wire
Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies,...
19 hours ago
Their company died. Their antimalarial drug lives on — with hopes of saving millions of lives - San Francisco Business ...
The Business Journals
Atreca's antibody discovery work goes back to 2012, after it spun out of work at a Stanford University lab and the Bill & Melinda Gates...
3 months ago
Atreca Announces Asset Purchase Agreement for Sale of Antibody-Related Assets and Materials to Immunome
Yahoo Finance
CAMPBELL, Calif., Dec. 26, 2023 (GLOBE NEWSWIRE) -- Atreca, Inc. (“Atreca”) (NASDAQ: BCEL), a biotechnology company focused on developing...
4 months ago
BCEL Stock Price and Chart — OTC:BCEL — TradingView
TradingView
Atreca, Inc. operates as a clinical-stage biopharmaceutical company, which engages in developing novel antibody-based therapeutics to treat a range of solid...
1 month ago
Former Big Pharma darling Atreca axes lead drug, 40% of staff in last-ditch pivot to ADCs
Fierce Biotech
The biotech has decided to stop work on its lead candidate, switch its focus to preclinical antibody-drug conjugates and lay off 40% of its...
9 months ago
Atreca Announces Agreement to Terminate Lease and Departure of Chief Financial Officer Herb Cross
GlobeNewswire
SAN CARLOS, Calif., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused...
7 months ago
Why Is Atreca (BCEL) Stock Up 85% Today?
InvestorPlace
Atreca stock is heading higher on Thursday as investors react to news of Baker Bros. Advisors LP increasing its stake in the company.
4 months ago
Atreca Reports Third Quarter 2023 Financial Results and Announces Further Reorganization to Support Exploration of ...
Yahoo Finance
SAN CARLOS, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused...
6 months ago
US Stocks Higher; Inflation Rate Increases To 3.4% In December - 180 Life Sciences (NASDAQ:ATNF), Atreca
Benzinga
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining over 50 points on Thursday. Following the market opening Thursday,...
4 months ago
Sera Prognostics, Atreca spike after Baker Bros stakes (NASDAQ:SERA)
Seeking Alpha
Shares of Sera Prognostics (SERA) and Atreca (BCEL) rise as hedge fund manager Baker Bros. Advisors discloses investments. Read more here.
4 months ago